166 related articles for article (PubMed ID: 28414026)
21. Signaling Rho-kinase mediates inflammation and apoptosis in T cells and renal tubules in cisplatin nephrotoxicity.
Nozaki Y; Kinoshita K; Hino S; Yano T; Niki K; Hirooka Y; Kishimoto K; Funauchi M; Matsumura I
Am J Physiol Renal Physiol; 2015 Apr; 308(8):F899-909. PubMed ID: 25651561
[TBL] [Abstract][Full Text] [Related]
22. LIGHT deficiency aggravates cisplatin-induced acute kidney injury by upregulating mitochondrial apoptosis.
Yang Y; Meng L; Wu S; Li Y; Zhong Y; Xu F; Zhou XC; Li GQ; Xu GL; Peng KF
Int Immunopharmacol; 2020 Dec; 89(Pt A):106999. PubMed ID: 33045563
[TBL] [Abstract][Full Text] [Related]
23. NAM protects against cisplatin-induced acute kidney injury by suppressing the PARP1/p53 pathway.
Wu W; Fu Y; Liu Z; Shu S; Wang Y; Tang C; Cai J; Dong Z
Toxicol Appl Pharmacol; 2021 May; 418():115492. PubMed ID: 33722665
[TBL] [Abstract][Full Text] [Related]
24. Mitigation of acute kidney injury by cell-cycle inhibitors that suppress both CDK4/6 and OCT2 functions.
Pabla N; Gibson AA; Buege M; Ong SS; Li L; Hu S; Du G; Sprowl JA; Vasilyeva A; Janke LJ; Schlatter E; Chen T; Ciarimboli G; Sparreboom A
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5231-6. PubMed ID: 25848011
[TBL] [Abstract][Full Text] [Related]
25. Histone methyltransferase MLL1 drives renal tubular cell apoptosis by p53-dependent repression of E-cadherin during cisplatin-induced acute kidney injury.
Zhang C; Guan Y; Zou J; Yang X; Bayliss G; Zhuang S
Cell Death Dis; 2022 Sep; 13(9):770. PubMed ID: 36068197
[TBL] [Abstract][Full Text] [Related]
26. Protective effect of concomitant administration of imatinib on cisplatin-induced nephrotoxicity focusing on renal organic cation transporter OCT2.
Tanihara Y; Masuda S; Katsura T; Inui K
Biochem Pharmacol; 2009 Nov; 78(9):1263-71. PubMed ID: 19540211
[TBL] [Abstract][Full Text] [Related]
27. FGF21 is induced in cisplatin nephrotoxicity to protect against kidney tubular cell injury.
Li F; Liu Z; Tang C; Cai J; Dong Z
FASEB J; 2018 Jun; 32(6):3423-3433. PubMed ID: 29401620
[TBL] [Abstract][Full Text] [Related]
28. Germacrone Reduces Cisplatin-Induced Toxicity of Renal Proximal Tubular Cells via Inhibition of Organic Cation Transporter.
Soodvilai S; Meetam P; Siangjong L; Chokchaisiri R; Suksamrarn A; Soodvilai S
Biol Pharm Bull; 2020; 43(11):1693-1698. PubMed ID: 33132314
[TBL] [Abstract][Full Text] [Related]
29. Dexmedetomidine protects against cisplatin-induced acute kidney injury in mice through regulating apoptosis and inflammation.
Liang H; Liu HZ; Wang HB; Zhong JY; Yang CX; Zhang B
Inflamm Res; 2017 May; 66(5):399-411. PubMed ID: 28224201
[TBL] [Abstract][Full Text] [Related]
30. MATE-1 modulation by kinin B1 receptor enhances cisplatin efflux from renal cells.
Estrela GR; Wasinski F; Felizardo RJF; Souza LL; Câmara NOS; Bader M; Araujo RC
Mol Cell Biochem; 2017 Apr; 428(1-2):101-108. PubMed ID: 28161805
[TBL] [Abstract][Full Text] [Related]
31. Paricalcitol prevents cisplatin-induced renal injury by suppressing apoptosis and proliferation.
Park JW; Cho JW; Joo SY; Kim CS; Choi JS; Bae EH; Ma SK; Kim SH; Lee J; Kim SW
Eur J Pharmacol; 2012 May; 683(1-3):301-9. PubMed ID: 22449373
[TBL] [Abstract][Full Text] [Related]
32. PPAR-α Deletion Attenuates Cisplatin Nephrotoxicity by Modulating Renal Organic Transporters MATE-1 and OCT-2.
Freitas-Lima LC; Budu A; Arruda AC; Perilhão MS; Barrera-Chimal J; Araujo RC; Estrela GR
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33049997
[TBL] [Abstract][Full Text] [Related]
33. Activation and involvement of p53 in cisplatin-induced nephrotoxicity.
Wei Q; Dong G; Yang T; Megyesi J; Price PM; Dong Z
Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1282-91. PubMed ID: 17670903
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory interaction of flavonoids with organic cation transporter 2 and their structure-activity relationships for predicting nephroprotective effects.
Tan H; Wang F; Hu J; Duan X; Bai W; Wang X; Wang B; Su Y; Hu J
J Appl Toxicol; 2023 Oct; 43(10):1421-1435. PubMed ID: 37057715
[TBL] [Abstract][Full Text] [Related]
35. Cisplatin nephrotoxicity: a review of the literature.
Manohar S; Leung N
J Nephrol; 2018 Feb; 31(1):15-25. PubMed ID: 28382507
[TBL] [Abstract][Full Text] [Related]
36. Magnesium improves cisplatin-mediated tumor killing while protecting against cisplatin-induced nephrotoxicity.
Kumar G; Solanki MH; Xue X; Mintz R; Madankumar S; Chatterjee PK; Metz CN
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F339-F350. PubMed ID: 28424213
[TBL] [Abstract][Full Text] [Related]
37. Klotho has dual protective effects on cisplatin-induced acute kidney injury.
Panesso MC; Shi M; Cho HJ; Paek J; Ye J; Moe OW; Hu MC
Kidney Int; 2014 Apr; 85(4):855-70. PubMed ID: 24304882
[TBL] [Abstract][Full Text] [Related]
38.
Zhang W; Hou J; Yan X; Leng J; Li R; Zhang J; Xing J; Chen C; Wang Z; Li W
Nutrients; 2018 Sep; 10(9):. PubMed ID: 30235825
[TBL] [Abstract][Full Text] [Related]
39. SIRT1 activation by resveratrol ameliorates cisplatin-induced renal injury through deacetylation of p53.
Kim DH; Jung YJ; Lee JE; Lee AS; Kang KP; Lee S; Park SK; Han MK; Lee SY; Ramkumar KM; Sung MJ; Kim W
Am J Physiol Renal Physiol; 2011 Aug; 301(2):F427-35. PubMed ID: 21593185
[TBL] [Abstract][Full Text] [Related]
40. Valsartan Protects Against Contrast-Induced Acute Kidney Injury in Rats by Inhibiting Endoplasmic Reticulum Stress-Induced Apoptosis.
Sun Y; Peng PA; Ma Y; Liu XL; Yu Y; Jia S; Xu XH; Wu SJ; Zhou YJ
Curr Vasc Pharmacol; 2017; 15(2):174-183. PubMed ID: 27781957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
